Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06107361 · ClinicalTrials.gov registry record · NA
Evaluating the Role of the Guidewire in Peripheral Intravenous Access: A Randomized Controlled Trial of Ultrasound-Guided Catheter Survival
A NA study of Peripheral Intravenous Vein Catheter Phlebitis and Intravenous Infection, sponsored by Corewell Health East.
- Recruiting
- Registry status
- NA
- Development phase
- 360
- Enrollment target
- 1
- Study location
NCT06107361: Recruiting NA study of Peripheral Intravenous Vein Catheter Phlebitis and Intravenous Infection, sponsored by Corewell Health East.
NCT06107361 is a NA study of Peripheral Intravenous Vein Catheter Phlebitis and Intravenous Infection that is actively recruiting participants, run by Corewell Health East. The registered enrollment target is 360 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06107361, a NA study of Peripheral Intravenous Vein Catheter Phlebitis and Intravenous Infection, is actively recruiting participants, sponsored by Corewell Health East.
- RECRUITING
- Registry status
- NA
- Development phase
- 360 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective, parallel, non-blinded, two-arm randomized controlled trial of intravenous catheter failure evaluating the impact of a built-in guide wire. The objective of this study is to demonstrate that the control ultralong intravenous catheter (IV) without the guide wire is non-inferior to the experimental catheter with the guide wire. After obtaining consent, eligible patients will be randomly allocated to control Arm 1 (ultralong intravenous catheter) or experimental Arm 2 (ultralong intravenous catheter with guide wire) in a ratio of 1:1 via a computer-generated randomization schedule. The participants will be followed to collect data until the catheter is removed.
Primary Outcome
Survival of catheter will be measured in hours from time of insertion to time of removal or failure. Functionality is defined as being able to aspirate blood and/or flush without resistance with 3-5 milliliters of saline. If unable, the catheter is considered to have failed.
Conditions Studied
Interventions
- DEVICE B. Braun 6.35cm 20 gauge ultralong intravenous catheter
- DEVICE BD 5.71 cm 20 gauge Accucath
Study Locations (1)
Michigan
- Beaumont Hospital - Royal Oak - Royal Oak
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 360 participants |
| Start Date | 2023-11-07 |
| Est. Completion | 2026-05 |
| Phase | NA |
What NCT06107361 shows while recruiting
NCT06107361 is an interventional study that assigns participants to a tested intervention. The registered 360 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower).
The record links to 2 conditions, with Peripheral Intravenous Vein Catheter Phlebitis appearing as the primary indexed condition, and to 2 interventions - of which B. Braun 6.35cm 20 gauge ultralong intravenous catheter is the first listed.
NCT06107361 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT06107361 about?
NCT06107361 is a clinical study titled "Evaluating the Role of the Guidewire in Peripheral Intravenous Access: A Randomized Controlled Trial of Ultrasound-Guided Catheter Survival". This is a prospective, parallel, non-blinded, two-arm randomized controlled trial of intravenous catheter failure evaluating the impact of a built-in guide wire. The objective of this study is to demonstrate that the control ultralong intravenous catheter (IV) without the guide wire is non-inferior ...
What is the current status of trial NCT06107361?
This trial is currently recruiting. It is a NA study. The enrollment target is 360 participants. The study started on 2023-11-07. Estimated completion is 2026-05.
What conditions does trial NCT06107361 study?
This clinical trial studies the following conditions: Peripheral Intravenous Vein Catheter Phlebitis, Intravenous Infection.
What interventions are being tested in trial NCT06107361?
The interventions under investigation include: B. Braun 6.35cm 20 gauge ultralong intravenous catheter (DEVICE), BD 5.71 cm 20 gauge Accucath (DEVICE).
Who is sponsoring clinical trial NCT06107361?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06107361 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06107361's enrollment target sits among peer trials
360 284th of 2000 higher than 1,713 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02747836 · 360 participants
Ultrasound Analysis of Human Carpal Tunnel System
- NCT04089046 · 360 participants · NA
Telemedicine Enhanced Asthma Management - Uniting Providers for Teens (TEAM-UP for Teens)
- NCT04130503 · 360 participants · NA
The Recovery in Stroke Using PAP Study
- NCT04160000 · 360 participants · Phase 4
Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI